Examining ISIS’s Turkish Sympathizers on Twitter
International Journal of Political Studies · 2022
DOI: 10.25272/icps.1183919 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Political Studies, 2022. Verfasst von Ahmet Yiğitalp TULGA. Die Arbeit nennt 73 Literaturangaben.
Abstract (Originalsprache)
Social media platforms have become a part of people's daily lives. However, developing social media technologies have affected not only people but also terrorist organizations such as the Islamic State of Iraq and Syria (ISIS), and social media has become an essential part of ISIS's strategies. ISIS effectively uses many social media platforms, especially Twitter, for propaganda, recruitment, and creating fear among people. ISIS also actively uses Twitter in Turkey. However, the number of academic studies focusing on the behavior, structure, communication, and relationship networks of ISIS sympathizers in Turkey is limited. Therefore, the main purpose of this study is to reveal the structure, behavior, communication, and relationship networks of ISIS's Turkish sympathizers. Accordingly, this study focuses on the structure, behavior, communication, and relationship networks of ISIS's Turkish sympathizers. I will analyze them within four main analytical steps. The basic characteristics, structures, behaviors, and relationship networks of 2079 Turkish ISIS sympathizers are examined with the R computer program, and many remarkable findings are reached as a result of the analysis.
Zitieren
APA
TULGA, A. Y. (2022). Examining ISIS’s Turkish Sympathizers on Twitter. International Journal of Political Studies. https://doi.org/10.25272/icps.1183919
Vancouver
TULGA AY. Examining ISIS’s Turkish Sympathizers on Twitter. International Journal of Political Studies. 2022. doi:10.25272/icps.1183919
BibTeX
@article{TULGA2022,
author = {TULGA, Ahmet Yiğitalp},
title = {Examining ISIS’s Turkish Sympathizers on Twitter},
journal = {International Journal of Political Studies},
year = {2022},
doi = {10.25272/icps.1183919}
}
EUVIMED